NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which MS treatment is known as a pyrimidine synthesis inhibitor?

Teriflunomide
Fingolimod
Natalizumab
Dimethyl Fumarate

The correct answer is: Teriflunomide

Teriflunomide is known as a pyrimidine synthesis inhibitor. This medication works by inhibiting the enzyme dihydroorotate dehydrogenase, which is involved in the de novo pyrimidine synthesis pathway. By inhibiting this enzyme, teriflunomide reduces the proliferation of activated lymphocytes, which play a role in the pathophysiology of multiple sclerosis (MS). The other options listed are incorrect: - Fingolimod is a sphingosine-1-phosphate receptor modulator. - Natalizumab is an integrin receptor antagonist. - Dimethyl Fumarate is thought to have immunomodulatory properties, but its exact mechanism of action in treating MS is not fully understood.